Human TNFSF9/4-1BB-L/CD137L ORF/cDNA clone-Lentivirus particle (NM_003811.3)
Cat. No.: vGMLV000252
Pre-made Human TNFSF9/4-1BB-L/CD137L Lentiviral expression plasmid for TNFSF9 lentivirus packaging, TNFSF9 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
4-1BBL/TNFSF9/TNFSF9/4-1BB-L products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
| Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
|---|---|---|---|
| vGMLV000252 | Human TNFSF9 Lentivirus particle | Pilot Grade | 1.0E+8TU |
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| Research Grade | 1.0E+8TU | ||
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMLV000252 |
| Gene Name | TNFSF9 |
| Accession Number | NM_003811.3 |
| Gene ID | 8744 |
| Species | Human |
| Product Type | Lentivirus particle (overexpression) |
| Insert Length | 765 bp |
| Gene Alias | 4-1BB-L,CD137L,TNLG5A |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGAATACGCCTCTGACGCTTCACTGGACCCCGAAGCCCCGTGGCCTCCCGCGCCCCGCGCTCGCGCCTGCCGCGTACTGCCTTGGGCCCTGGTCGCGGGGCTGCTGCTGCTGCTGCTGCTCGCTGCCGCCTGCGCCGTCTTCCTCGCCTGCCCCTGGGCCGTGTCCGGGGCTCGCGCCTCGCCCGGCTCCGCGGCCAGCCCGAGACTCCGCGAGGGTCCCGAGCTTTCGCCCGACGATCCCGCCGGCCTCTTGGACCTGCGGCAGGGCATGTTTGCGCAGCTGGTGGCCCAAAATGTTCTGCTGATCGATGGGCCCCTGAGCTGGTACAGTGACCCAGGCCTGGCAGGCGTGTCCCTGACGGGGGGCCTGAGCTACAAAGAGGACACGAAGGAGCTGGTGGTGGCCAAGGCTGGAGTCTACTATGTCTTCTTTCAACTAGAGCTGCGGCGCGTGGTGGCCGGCGAGGGCTCAGGCTCCGTTTCACTTGCGCTGCACCTGCAGCCACTGCGCTCTGCTGCTGGGGCCGCCGCCCTGGCTTTGACCGTGGACCTGCCACCCGCCTCCTCCGAGGCTCGGAACTCGGCCTTCGGTTTCCAGGGCCGCTTGCTGCACCTGAGTGCCGGCCAGCGCCTGGGCGTCCATCTTCACACTGAGGCCAGGGCACGCCATGCCTGGCAGCTTACCCAGGGCGCCACAGTCTTGGGACTCTTCCGGGTGACCCCCGAAATCCCAGCCGGACTCCCTTCACCGAGGTCGGAATAA |
| ORF Protein Sequence | MEYASDASLDPEAPWPPAPRARACRVLPWALVAGLLLLLLLAAACAVFLACPWAVSGARASPGSAASPRLREGPELSPDDPAGLLDLRQGMFAQLVAQNVLLIDGPLSWYSDPGLAGVSLTGGLSYKEDTKELVVAKAGVYYVFFQLELRRVVAGEGSGSVSLALHLQPLRSAAGAAALALTVDLPPASSEARNSAFGFQGRLLHLSAGQRLGVHLHTEARARHAWQLTQGATVLGLFRVTPEIPAGLPSPRSE |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-IO001-Ab | Anti-TNFL9/ 4-1BBL/ TNFSF9 monoclonal antibody |
| Target Antigen | GM-Tg-g-IO001-Ag | 4-1BBL/TNFSF9 VLP (virus-like particle) |
| Cytokine | cks-Tg-g-GM-IO001 | tumor necrosis factor (ligand) superfamily, member 9 (TNFSF9) protein & antibody |
| ORF Viral Vector | pGMLV000252 | Human TNFSF9 Lentivirus plasmid |
| ORF Viral Vector | vGMLV000252 | Human TNFSF9 Lentivirus particle |
Target information
| Target ID | GM-IO001 |
| Target Name | 4-1BBL/TNFSF9 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
8744 |
| Gene ID |
101087207 (Felis catus), 102150292 (Equus caballus), 21950 (Mus musculus), 353218 (Rattus norvegicus) 476729 (Canis lupus familiaris), 521748 (Bos taurus), 700588 (Macaca mulatta), 8744 (Homo sapiens) |
| Gene Symbols & Synonyms | TNFSF9,Tnfsf9,Ly63l,4-1BBL,Cd137l,4-1BB-L,Tnlg5a,TNLG5A,CD137L |
| Target Alternative Names | 4-1BB ligand (4-1BBL),4-1BB-L,4-1BBL,CD137L,Cd137l,Ly63l,TNFSF9,TNLG5A,Tnfsf9,Tnlg5a,Tumor necrosis factor ligand superfamily member 9 |
| Uniprot Accession |
P41273,P41274
Additional SwissProt Accessions: P41274,P41273 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, Immuno-oncology Target, Cytokine Target |
| Disease | |
| Disease from KEGG | Cytokine-cytokine receptor interaction |
| Gene Ensembl | ENSECAG00000022714, ENSMUSG00000035678, ENSBTAG00000046266, ENSMMUG00000001985, ENSG00000125657 |
| Target Classification | Checkpoint-Immuno Oncology |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


